Cite
HARVARD Citation
Neukirchen, J. et al. (2017). Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis. Cancer. 123 (23), pp. 4608-4616. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Neukirchen, J. et al. (2017). Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis. Cancer. 123 (23), pp. 4608-4616. [Online].